NMRD Launches App & Begins Pilot Distribution

Posted on April 13, 2021 by Aaron Warwick

Today, Nemaura Medical (NMRD), a medical technology company focused on developing and commercializing non-invasive wearable diagnostic devices and supporting personalized lifestyle coaching programs, announced the launch of its BEATdiabetes app on the GooglePlay and iOS platforms. The interactive app provides predictive information such as smart eating choices, exercise and other potential lifestyle changes over the long term based on information provided by the user. It also features continuous one-on-one support through its AI avatar, Lena, who learns about user habits and regularly becomes more familiar with each user. As new information is processed, Lena offers feedback and encouragement as well as helpful ideas to help users improve their health. The program is based on an in-clinic program originally developed and validated at the Joslin Diabetes Centre.

The Company is also beginning pilot programs that include its proprietary proBEAT monitor, a non-invasive, daily-wear glucose monitoring patch, synced with the BEATdiabetes program. CEO Faz Chowdhury: “We believe our pilot program which includes our proBEAT non-invasive glucose sensor ushers in a new era in the development of life management tools that have been scientifically validated and utilize a personalized coaching method that combines a digital platform with data from a unique non-invasive device.”

The CEO further hinted at future news to come: “We have initially adopted a business-to-business model and are actively exploring a range of options for broad distribution of this combined program through U.S. insurers and employee wellness programs. We look forward to discussing further distribution of the proBEAT monitor and associated programs as we progress our commercial initiatives.”

Disclosure: I am long NMRD and may buy/sell shares at any time.

5 1 vote
Article Rating
Subscribe
Notify of
0 Comments
Inline Feedbacks
View all comments
0
Would love your thoughts, please comment.x
()
x